Further, we documented that in each of the five astrocytoma/glioblastoma cell lines studied (U-87 MG, T98G, U-251 MG, U-373 MG, U-138 MG), fully formed primary cilia ...

Inclusion criteria were newly diagnosed glioblastoma (WHO GRADE IV ASTROCYTOMA), a performance status of ≤2, and adequate renal, hematologic, and hepatic function. Patients were randomly ...

The Phase III STELLAR trial evaluated the eflornithine and lomustine combination in patients with IDH mutant astrocytoma.